Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Gynecol Oncol. 2014 Jun 24;134(3):581–590. doi: 10.1016/j.ygyno.2014.06.013

Fig. 3. Kaplan-Meier plots of OS and PFS by iCTCs (A), serum CA125 (B), iCTCs and tumor stage (C), and serum CA125 and tumor stage (D).

Fig. 3

Negative samples are defined as ≤5 iCTCs/1-mL blood and ≤35U/mL serum CA125 levels. The difference between negative and positive groups is evaluated for significance based on the log-rank test. Relative numbers of patients with negative (top) and positive (bottom) iCTCs and serum CA125 are indicated below the year on x-axis.